Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

[HDL receptor]

S Takahashi1, T Tamai, T Nakai

  • 1Third Department of Internal Medicine, Fukui Medical School.

Nihon Rinsho. Japanese Journal of Clinical Medicine
|December 1, 1994
PubMed
Summary
This summary is machine-generated.

High-density lipoprotein cholesterol (HDL-C) protects against heart disease. Research explores the HDL receptor, reverse cholesterol transport, and HDL

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

[Diagnostic imaging of polysplenia syndrome in the adult].

Nihon Igaku Hoshasen Gakkai zasshi. Nippon acta radiologica·1992
Same author

Interaction of alpha subunit of GTP-binding protein Go with a 20-kDa Triton-insoluble membrane protein in bovine brain.

FEBS letters·1992
Same author

Effect of cilostazol, a cyclic AMP phosphodiesterase inhibitor, on the proliferation of rat aortic smooth muscle cells in culture.

Journal of cardiovascular pharmacology·1992
Same author

Transfer of plutonium to rat embryos in vivo and in vitro.

Journal of radiation research·1992
Same author

Growth hormone secretion in old female rats analyzed by the reverse hemolytic plaque assay.

Acta endocrinologica·1992
Same author

Pathological markers for non-genotoxic agent-associated carcinogenesis.

Toxicology letters·1992
Same journal

[Development of novel therapeutics for multiple myeloma and improvement of drug lag].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Clinical pharmacy services to patients of immunomodulatory drugs].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Therapeutic drug monitoring of the new anti-myeloma drugs in the treatment of multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Prognostic value of minimal residual disease assessment using next-generation sequencing in multiple myeloma].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[The evaluation of minimal residual disease in multiple myeloma by an allele-specific oligonucleotide real-time PCR].

Nihon rinsho. Japanese journal of clinical medicine·2019
Same journal

[Evaluation of minimal residual disease in myeloma by multiparametric flow cytometry].

Nihon rinsho. Japanese journal of clinical medicine·2019
See all related articles

Area of Science:

  • Biochemistry and Molecular Biology
  • Cardiovascular Research
  • Lipid Metabolism

Context:

  • High-density lipoprotein cholesterol (HDL-C) is inversely correlated with coronary heart disease (CHD) risk.
  • Understanding HDL's role is crucial for cardiovascular health.
  • Recent research focuses on HDL receptors and reverse cholesterol transport.

Purpose:

  • To review current data on HDL receptors, reverse cholesterol transport, and HDL's antiatherogenic effects.
  • To discuss the characterization of HDL binding protein (HBP) and its potential receptor function.
  • To examine the role of apolipoproteins in HDL's protective functions.

Summary:

  • HDL binding protein (HBP) characterization has yielded inconsistent results, suggesting it may not be a classical plasma membrane receptor.

Related Experiment Videos

  • Reverse cholesterol transport involves multiple steps, notably CETP-mediated cholesteryl ester transfer from HDL to VLDL/LDL.
  • Transgenic mouse models show apolipoprotein A-I confers an antiatherogenic effect, while apolipoprotein A-II does not.
  • Impact:

    • Clarifies the complex nature of HDL receptors and their function in cholesterol metabolism.
    • Highlights the antiatherogenic potential of apolipoprotein A-I.
    • Provides insights into developing novel strategies for preventing and treating atherosclerosis.